Trials / Unknown
UnknownNCT05691179
COVID-19 Infection and Idiopathic Membranous Nephropathy
The Association of COVID-19 Infection and Relapse of Idiopathic Membranous Nephropathy
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 130 (estimated)
- Sponsor
- Beijing Friendship Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- —
Summary
Infection is one of common risk factors for relapsing of idiopathic membranous nephropathy (IMN). However, it is still unclear wheather COVID-19 infection can induce the relapsing of IMN. Herein, in this prospective, multi-center, cohort study, the investigator enrolled the IMN patients with COVID-19 infection. All subjects will be followed for three months with four visits at 1, 2 and 3 months. Then the investigator will compare the rate of replase of IMN in the two groups to evaluate the association of COVID-19 infection and replapse of IMN.
Conditions
Timeline
- Start date
- 2022-12-10
- Primary completion
- 2023-05-31
- Completion
- 2023-05-31
- First posted
- 2023-01-19
- Last updated
- 2023-02-14
Locations
3 sites across 1 country: China
Source: ClinicalTrials.gov record NCT05691179. Inclusion in this directory is not an endorsement.